Breaking News
NASA's "Alien Probe" & The Comet Cover Story -- with Clay Clark
A Troubled $140 Billion Bet on China Property Gets Even Worse
A new generation of cash on-chain
So is that what the #DigitalID is all about? To be able ???????? ???????????????????????? ??????????
Top Tech News
Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
AstraZeneca Coronavirus Vaccine to Be Pulled Worldwide for 'Commercial' Reasons
The Oxford-AstraZeneca coronavirus vaccine will be withdrawn worldwide just months after the firm admitted that the jab causes a rare but dangerous side effect, however, AstraZeneca insists that the decision to pull the vaccine was purely made for commercial reasons.
AstraZeneca pulled its "marketing authorisation" for its COVID-19 vaccine, known commercially as Vaxzevria, in the European Union on Tuesday and plans to do so in the UK and other countries where it was deployed in the coming months. The decision will not impact the United States, where the jab never received approval to go to market.
The pharmaceutical giant insisted that the decision was made for commercial considerations, saying that the vaccine is no longer being manufactured and that more recent vaccines have been developed to confront novel variants of the Chinese virus.